Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Freeman

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
The Journal of Infectious Diseases|April 1, 1991
The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovirS L Spruance, D J Freeman, J C Stewart, et al.
Immuno-Oncology Technology|June 27, 2022
Intervention strategies for microbial therapeutics in cancer immunotherapyV Gopalakrishnan, B Weiner, C B Ford, et al.
Clinical Chemistry|October 1, 1990
Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panelL M Shaw, R W Yatscoff, L D Bowers, et al.
Journal of Clinical Pharmacology|April 21, 2011
In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesnaM J Cutler, B L Urquhart, T J Velenosi, et al.
Circulation|February 7, 2001
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyD J Freeman, J Norrie, N Sattar, et al.
Diabetologia|November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderlyN Sattar, H M Murray, P Welsh, et al.
Circulation|January 19, 2005
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjectsS M Boekholdt, F M Sacks, J W Jukema, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
The Journal of Infectious Diseases|April 1, 1991
The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovirS L Spruance, D J Freeman, J C Stewart, et al.
Immuno-Oncology Technology|June 27, 2022
Intervention strategies for microbial therapeutics in cancer immunotherapyV Gopalakrishnan, B Weiner, C B Ford, et al.
Clinical Chemistry|October 1, 1990
Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panelL M Shaw, R W Yatscoff, L D Bowers, et al.
Journal of Clinical Pharmacology|April 21, 2011
In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesnaM J Cutler, B L Urquhart, T J Velenosi, et al.
Circulation|February 7, 2001
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyD J Freeman, J Norrie, N Sattar, et al.
Diabetologia|November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderlyN Sattar, H M Murray, P Welsh, et al.
Circulation|January 19, 2005
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjectsS M Boekholdt, F M Sacks, J W Jukema, et al.
Pageof 11